Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors von Langenfeld, Elaine M, Langenfeld, John

Volltext

Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1 5 von Langenfeld, E M, Kong, Y, Langenfeld, J

Volltext

Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus : Results from a controlled randomized study von LANGENFELD, M. R, FORST, T, HOHBERG, C, KANN, P, LÜBBEN, G, KONRAD, T, FÜLLERT, S. D, SACHARA, C, PFÜTZNER, A

Volltext

The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells von Langenfeld, Elaine M., Calvano, Steve E., Abou-Nukta, Fadi, Lowry, Stephen F., Amenta, Peter, Langenfeld, John

Volltext

Expression of Bone Morphogenetic Proteins in Human Lung Carcinomas von Langenfeld, Elaine M., Bojnowski, John, Perone, John, Langenfeld, John

Volltext

Bone Morphogenetic Protein-2–Induced Transformation Involves the Activation of Mammalian Target of Rapamycin von Langenfeld, Elaine M, Kong, Yingxin, Langenfeld, John

Volltext

Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation von Lattimore, J L, Wilcox, I, Skilton, M, Langenfeld, M, Celermajer, D S

Volltext

Impact of dietary sodium intake on left ventricular diastolic filling in early essential hypertension von Langenfeld, M. R. W., Schobel, H., Veelken, R., Weihprecht, H., Schmieder, R. E.

Volltext

Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension von SCHMIEDER, R. E, LANGENFELD, M. R. W, FRIEDRICH, A, SCHOBEL, H. P, GATZKA, C. D, WEIHPRECHT, H

Volltext

1166 A/C polymorphism of the angiotensin II type 1 receptor gene and the response to short-term infusion of angiotensin II von HILGERS, K. F, LANGENFELD, M. R. W, SCHLAICH, M, VEELKEN, R, SCHMIEDER, R. E

Volltext

PCN61 Impact of Appropriate Treatment Informed by EGFR Mutation Status on Patient Outcomes from Diagnosis to Death in Advanced Non-Small Cell Lung Cancer von Teale, C, Parasuraman, B, van der Scheer, F, Langenfeld, M, Ruff, L, Hanmore, E

Volltext

Does Lipoprotein(a) Impair Endothelial Function? von Schlaich, Markus P, John, Stefan, Langenfeld, Matthias R.W, Lackner, Karl J, Schmitz, Gerd, Schmieder, Roland E

Volltext

Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic control : Results from the pioneer study von PFÜTZNER, Andreas, MARX, Nikolaus, LÜBBEN, Georg, LANGENFELD, Matthias, WALCHER, Daniel, KONRAD, Thomas, FORST, Thomas

Volltext

PIH4 An Economic Comparison of Treatment Strategies with Anakinra in Systemic Juvenile Idiopathic Arthritis (SJIA) von Bullement, A., Knowles, E., van Leeuwen-Gorter, A., Langenfeld, M., Reynolds Diogo, G., Nazir, J., Eriksson, D.

Volltext

Abstract OT3-04-04: 21-gene recurrence score® in patients with primary metastatic ER+ HER2- breast cancer von Barinoff, J, Anastasiadou, L, Brandi, C, Junker-Stein, A, Silbermann, J, Langenfeld, M, Fortmann, C, Thill, M

Volltext

Synchronous Oligometastatic Non-small Cell Lung Cancer Managed With Curative-Intent Chemoradiation Therapy: Long-term Outcomes From a Single Institution von Yegya-Raman, Nikhil, MD, Aisner, Joseph, MD, Kim, Sinae, PhD, Sayan, Mutlay, MD, Li, Diana, BA, Langenfeld, John, MD, Patel, Malini, MD, Malhotra, Jyoti, MD, MPH, Jabbour, Salma K., MD

Volltext

IRIS II study: the IRIS II score-assessment of a new clinical algorithm for the classification of insulin resistance in patients with Type 2 diabetes von Forst, T., Standl, E., Hohberg, C., Konrad, T., Schulze, J., Strotmann, H. J., Lübben, G., Pahler, S., Bachinger, A., Langenfeld, M., Pfützner, A.

Volltext

PCN37 BI OF IRESSA IN NSCLC IN THE NETHERLANDS:A HOSPITAL PERSPECTIVE von Langenfeld, M, Scheer, F

Volltext

An Economic Comparison of Treatment Strategies with Anakinra in Systemic Juvenile Idiopathic Arthritis (sJIA) von Bullement, Ash, Knowles, Emma S, Langenfeld, Merel, Diogo, Gil Reynolds, Nazir, Jameel, Eriksson, Daniel

Volltext

Is endogenous erythropoietin a pathogenetic factor in the development of essential hypertension? von LANGENFELD, M. R. W, VEELKEN, R, SCHOBEL, H. P, FRIEDRICH, A, SCHMIEDER, R. E

Volltext